Vistagen Therapeutics (VTGN) EBITDA (2011 - 2026)
Vistagen Therapeutics (VTGN) recorded EBITDA of -$13.3 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$15.76 million a year earlier.
Powered by 
Analysis
Vistagen Therapeutics (VTGN) EBITDA (2011 - 2026) Analysis & Trends
On a TTM basis, Vistagen Therapeutics' EBITDA came in at -$69.45 million as of Jun 30, 2026; for FY2026 (ended Mar 31, 2026), it came in at -$71.93 million.
- Across earlier fiscal years, EBITDA came in at -$55.82 million in FY2025, -$32.89 million in FY2024 and -$59.14 million in FY2023.
- The fiscal Q1 2027 figure is the highest quarterly EBITDA since fiscal Q1 2025.
- Per Business Quant, the preceding three fiscal quarters came in at -$16.67 million (Q4 2026), -$19.49 million (Q3 2026) and -$20 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Vistagen Therapeutics | 13.76 Mn | 13.76 Mn | - | -13.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.30 Mn |
| Mar 31, 2026 | -16.67 Mn |
| Dec 31, 2025 | -19.49 Mn |
| Sep 30, 2025 | -20.00 Mn |
| Jun 30, 2025 | -15.76 Mn |
| Mar 31, 2025 | -14.46 Mn |
| Dec 31, 2024 | -15.08 Mn |
| Sep 30, 2024 | -14.19 Mn |
| Jun 30, 2024 | -12.10 Mn |
| Mar 31, 2024 | -11.33 Mn |
| Dec 31, 2023 | -7.85 Mn |
| Sep 30, 2023 | -6.75 Mn |
| Jun 30, 2023 | -6.97 Mn |
| Mar 31, 2023 | -12.21 Mn |
| Dec 31, 2022 | -9.74 Mn |
| Sep 30, 2022 | -17.46 Mn |
| Jun 30, 2022 | -19.74 Mn |
| Dec 31, 2021 | -10.50 Mn |
| Sep 30, 2021 | -12.76 Mn |
| Jun 30, 2021 | -7.71 Mn |
API Access
Vistagen Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();